September 24-25, 2012 – Biosimilars and Biobetters*** (SMi) – London, UK

September 25-26, 2012 – EU Pharma Regulatory Law*** (C5) – Brussels, Belgium

September 27, 2012 – Cross Winds in the Safe Harbor: Classen
v. Biogen and Momenta v. Amphastar (Intellectual Property Owners Association) – 1:00 pm (ET)

September 28, 2012 – Focus on Biologics and Biosimilars (Catalyzing Collaboration Between Industry and Academia in the Life Sciences) – Hospira, Inc., Lake Forest, IL

October 2, 2012 – Single Claim Restriction
Requirements: The Interplay Between 35 USC § 112 and 35 USC § 121 (American Bar
Association) – 12:00 – 1:30 pm (Eastern)

October 4,
2012 – Myriad: The Gene Patent Fight Continues . . . (Technology
Transfer Tactics) – 1:00 – 2:00 pm (Eastern)

October 10-11, 2012 – Maximizing Pharmaceutical Patent Lifecycles*** (ACI) – New York, NY

October 10-11, 2012 – Biotech & Pharmaceutical Patenting*** (C5) – London, UK

October 11, 2012 – 2012 Intellectual Property
Continuing Legal Education Seminar (DuPont and the
Widener University School of Law) – Wilmington, DE

October 22-23, 2012 – Tech Transfer Summit North America*** (Tech Transfer Summit Ltd.) – John Hopkins University, Montgomery County, MD

October 23, 2012 – Biosimilars: Draft FDA Guidance and Emerging Legal Challenges (Strafford) – 1:00 – 2:30 pm (EDT)

October 24-25, 2012 – FDA Boot Camp Devices Edition*** (American Conference Institute) – Chicago, IL

October 25-26, 2012 – Life Sciences Congress on
Paragraph IV Disputes (Center for
Business Intelligence) – Washington, DC

October 25-27, 2012 – AIPLA 2012 Annual Meeting (American
Intellectual Property Law Association) – Washington, DC

November 28-29, 2012 – Biotech Patents*** (American Conference
Institute) – Boston, MA

November 28-29, 2012 – Orphan Drugs and Rare Diseases*** (American Conference
Institute) – Boston, MA

December 3-5, 2012 – Drug and Medical Device
Litigation*** (American Conference
Institute) – New York, NY

***Patent Docs is a media partner of this conference or CLE